| Literature DB >> 20148160 |
Jules Angst1, Thomas D Meyer, Rolf Adolfsson, Peter Skeppar, Mauro Carta, Franco Benazzi, Ru-Band Lu, Yi-Hsuan Wu, Hai-Chen Yang, Cheng-Mei Yuan, Paolo Morselli, Peter Brieger, Judith Katzmann, Ines Alice Teixeira Leão, José Alberto Del Porto, Doris Hupfeld Moreno, Ricardo A Moreno, Odeilton T Soares, Eduard Vieta, Alex Gamma.
Abstract
This study examined the transcultural robustness of a screening instrument for hypomania, the Hypomania Checklist-32, first revised version (HCL-32 R1). It was carried out in 2606 patients from twelve countries in five geographic regions (Northern, Southern and Eastern Europe, South America and East Asia). In addition, GAMIAN Europe contributed data from its members. Exploratory and confirmatory factor analyses were used to examine the transregional stability of the measurement properties of the HCL-32 R1, including the influence of sex and age as covariates. Across cultures, a two-factor structure was confirmed: the first factor (F1) reflected the more positive aspects of hypomania (being more active, elated, self-confident, and cogni-tively enhanced); the second factor (F2) reflected the more negative aspects (being irritable, impulsive, careless, more substance use). The measurement properties of the HCL-32 R1 were largely invariant across cultures. Only few items showed transcultural differences in their relation to hypomania as measured by the test. F2 was higher among men and in more severe manic syndromes; F1 was highest in North and East Europe and lowest in South America. The scores decreased slightly with age. The frequency of the 32 items showed remarkable similarities across geographic areas, with two excep-tions: South Europeans had lower symptom frequencies in general and East Europeans higher rates of substance use. These findings support the interna-tional applicability of the HCL-32 R1 as a screening instrument for hypomania.Entities:
Keywords: HCL-32 R1,; Hypomania,; transcultural robustness
Year: 2010 PMID: 20148160 PMCID: PMC2816932 DOI: 10.1002/j.2051-5545.2010.tb00268.x
Source DB: PubMed Journal: World Psychiatry ISSN: 1723-8617 Impact factor: 49.548